Report
Sharad Kumar S.P

Whitestone Group Acquisition Of 69% Of Lambda-X

Whitestone Group has acquired 69% of Lambda-X Ophthalmics (LXO) for €5.3m. The rest of the company will be owned by company management (17%) and Invest.BW (14%). Lambda-X Ophthalmics is a division of the Verhaert Group. Lambda-X has developed an exclusive, high value-added range of instruments (NIMO) and software for measuring and characterizing ophthalmic lenses (contact, intraocular) as well as spectacle lenses with special geometries. We welcome this news as after consecutive capital raises, Whitestone Group was sitting on ~€27.6m worth of cash which had to be deployed. Additionally, the new stake in Lambda-X Ophthalmics will add a new layer of diversification in terms of sectors. We reiterate our BUY rating and €14.2 TP.
Underlying
WHITESTONE GROUP

Provider
KBC Securities
KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Analysts
Sharad Kumar S.P

Other Reports on these Companies
Other Reports from KBC Securities

ResearchPool Subscriptions

Get the most out of your insights

Get in touch